003220.KO Daewon Pharmaceutical Co. Ltd.

Healthcare Pharmaceuticals Korea Stock Exchange
8,190 KRW
Close of Nov 4, 2026
7,060 13,670
Market cap
KRW 176B
P/E
37.1x
P/B
0.64x
ROE
4.8%
Dividend yield
3.66%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 003220.KO undervalued?

Graham number
Price8,190
Graham value7,955
Premium3.0%

003220.KO trades 3.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Daewon Pharmaceutical Co. Ltd. fundamental analysis

No fundamental analysis for Daewon Pharmaceutical Co. Ltd. yet.

Daewon Pharmaceutical Co. Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Daewon Pharmaceutical Co. Ltd.

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicin…

Full company profile